Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $1.11 Million - $1.28 Million
7,659 Added 115.03%
14,317 $2.28 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $530,142 - $635,779
3,833 Added 135.68%
6,658 $1.08 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $379,143 - $434,852
2,825 New
2,825 $379,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Exos Tfp Holdings LLC Portfolio

Follow Exos Tfp Holdings LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exos Tfp Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exos Tfp Holdings LLC with notifications on news.